In the continually evolving world of healthcare, it is unequivocally critical that prevention professionals are well-acquainted with emerging issues. This is particularly significant in sectors that deal with infection prevention and control, often grappling with the menacing threats posed by antimicrobial-resistant bacteria causing wound infections, especially in underdeveloped regions.
A recent study conducted over a period of nine years (2015-2023) offered novel insights into the bacterial spectrum and antimicrobial resistance patterns of wound isolates collected at the Skin and Venereal Disease Prevention and Control Hospital, based in Shantou, China. This location is worthy of attention due to Shantou’s healthcare challenges, which make it representative of similar underdeveloped regions. The research was rooted in a large sample pool comprising 790 wound specimens, each processed using standard microbiological techniques.
The study harbored some intriguing findings. For instance, Staphylococcus aureus emerged as the main culprit behind wound infections, prevalent in a staggering 39.4% of cases. Other common pathogens included Klebsiella pneumoniae (12.4%), Pseudomonas aeruginosa (6.89%), Staphylococcus haemolyticus (6.21%), Staphylococcus epidermidis (5.88%), and Escherichia coli (5.21%). Bearing in mind the gender demographics, male patients accounted for a higher percentage of infections, 363 of 420 (86.4%), compared to females, who accounted for 232 out of 370 cases (62.7%). The 2-17 year age group was found to have the highest incidence at 25.0%, followed by those aged 51–60 years at 14.9%.
When exploring resistance patterns, certain bacteria were identified as extended-spectrum beta-lactamase (ESBL) producers, specifically 41.9% of E. coli and 29.7% of K. pneumoniae. With regards to Gram-positive multidrug-resistant (MDR) isolates, S. haemolyticus (91.8%), S. epidermidis (91.4%), and S. aureus (73.9%) showed the highest resistance. Furthermore, methicillin-resistant Staphylococcus aureus (MRSA) comprised a prominent share, 68.5% of S. aureus, with high resistance to penicillin (97.3%) and erythromycin (73.5%).
The results underscore the urgent need for culture-guided therapy and stringent antibiotic stewardship, given the high prevalence of MRSA (68.5%) and MDR S. aureus (73.6%). As a potential catalyst for the misuse of antibiotics, the management and mitigation of antibiotic resistance deserve the undivided attention and concerted efforts of all healthcare professionals working within the domains of infection control, treatment, and prevention.